Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Interim Management Statement

16 May 2011 10:33

RNS Number : 6513G
Dunedin Enterprise Inv Trust PLC
16 May 2011
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Interim Management Statement

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") presents its Interim Management Statement for the quarter ended 31 March 2011. This is the Company's first interim management statement for the financial year to 31 December 2011, as required by the FSA Disclosure and Transparency Rule 4.3.

 

1. Investment Objective

 

Dunedin Enterprise specialises in the provision of private equity finance. Private equity is medium to long term finance provided in return for an equity stake in established, potentially high growth private companies. The Company's investment objective is to achieve substantial long term capital growth in its assets through capital gains from its investments.

 

2. Unaudited net asset value per share

 

The unaudited net asset value per share at 31 March 2011 was 509.2p. This represents an increase of 2.4% from the level at 31 December 2010.

 

3. Share price and discount

 

The share price rose by 3.7% from 300p to 311p in the quarter to 31 March 2011. This compares to a decrease in the FTSE Small Cap Index of 0.1% over the same period.

 

Based upon the net asset value per share of 509.2p, the discount of the share price to the net asset value per share has remained largely unchanged moving from 39.7% to 38.9% in the quarter. When cash is excluded from net assets then the discount increases to 50.1%.

 

The share price at the close of business on 13 May 2011 was 355p, which was 14.1% higher than at 31 March 2011. The share price of 355p represents a discount of 30.3% to the net asset value per share of 509.2p and when cash is excluded from net assets then the discount increases to 39.0%.

 

4. Balance Sheet

 

The balance sheet as at 31 March 2011 is noted below:-

 

 
£'m
Investments:-
 
Dunedin managed
86.7
Third party managed
15.1
Listed private equity
16.1
Legacy technology funds
1.8
 
119.7
Cash and near cash
34.3
Other assets/liabilities 
(0.3)
Total net assets
153.7
 
 
Net asset value per share (p)
509.2

  

5. Valuations

 

The portfolio of investments has been revalued at 31 March 2011. The increase in net asset value in the quarter can be attributed to:-

 

·; an increase in the value of European fund investments of £2.4m due to a combination at the portfolio company level of strong trading, de-gearing and a movement from cost to an earnings based valuation,

·; an increase in the value of the SWIP Private Equity Fund of Funds II PLC of £1.8m due to an increase in underlying fund values,

·; a reduction of £0.3m following the sale of the European listed investments, and

·; other movements of -£0.3m.

 

6. Commitments

 

As at 31 March 2011 the Company has outstanding capital commitments to limited partnership funds of £77.4m. In addition to cash and near cash balances of £34.3m at 31 March 2011 the Company has a listed private equity investment (SWIP) of £16.1m.

 

7. Outlook

 

The number of new business opportunities is encouraging, but the market remains very competitive.

 

 

For further information on Dunedin Enterprise please go to www.dunedin.com

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGCGDUBXBBGBL
Date   Source Headline
27th Mar 200711:41 amRNSHolding(s) in Company
22nd Mar 20071:57 pmRNSHolding(s) in Company
19th Mar 20072:58 pmRNSHolding(s) in Company
6th Mar 200710:21 amRNSHolding(s) in Company
2nd Mar 20075:47 pmRNSTransaction in Own Shares
2nd Mar 20075:24 pmRNSHolding(s) in Company
1st Mar 200712:08 pmRNSDirector/PDMR Shareholding
6th Feb 20072:06 pmRNSHolding(s) in Company
5th Feb 20075:35 pmRNSDirector/PDMR Shareholding
5th Feb 200711:11 amRNSPortfolio Update
17th Jan 200712:36 pmRNSTotal Voting Rights
3rd Jan 20079:08 amRNSDirectorate Change
15th Dec 20067:58 amRNSInterim Results
4th Dec 200612:47 pmRNSNotice of Results
16th Nov 200611:38 amRNSHolding(s) in Company
6th Nov 20067:00 amRNSDirector Declaration
1st Nov 200612:02 pmRNSPortfolio Update
12th Sep 20065:15 pmRNSResult of AGM
2nd Aug 20069:59 amRNSPortfolio Update
21st Jun 20066:15 pmRNSTransaction in Own Shares
19th Jun 20067:01 amRNSFinal Results
8th Jun 20063:12 pmRNSNotice of Results
23rd May 20067:02 amRNSFund Commitment
11th May 200612:05 pmRNSHolding(s) in Company
3rd May 200612:14 pmRNSPortfolio Update
21st Apr 20063:34 pmRNSHolding(s) in Company
7th Apr 20062:11 pmRNSSale of Investment
24th Mar 200612:39 pmRNSDirector/PDMR Shareholding
9th Mar 20063:05 pmRNSSale of Investment
9th Mar 20067:00 amRNSStatement re. Press Comment
27th Feb 20062:32 pmRNSDisposal of Investment
14th Feb 200610:53 amRNSHolding(s) in Company
25th Jan 20061:51 pmRNSDirector/PDMR Shareholding
21st Dec 200510:22 amRNSHolding(s) in Company
20th Dec 20058:15 amRNSHolding(s) in Company
19th Dec 200511:25 amRNSHolding(s) in Company
19th Dec 20059:17 amRNSHolding(s) in Company
15th Dec 20057:00 amRNSInterim Results
30th Nov 20052:55 pmRNSNotice of Results
22nd Nov 200510:56 amRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRealisation of IPO proceeds
10th Nov 20054:58 pmRNSHolding(s) in Company
1st Nov 200510:19 amRNSPortfolio Update
12th Sep 20054:51 pmRNSResult of AGM
3rd Aug 200512:22 pmRNSPortfolio Update
20th Jun 20059:35 amRNSDirector Shareholding
16th Jun 20057:00 amRNSFinal Results
31st May 20057:01 amRNSHolding(s) in Company
24th May 20057:00 amRNSNotice of Results
18th May 20059:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.